QURE - ユニキュア (uniQure N.V.)

QUREのニュース

   Moving Average Crossover Alert: uniQure  2020/06/01 13:29:00 Zacks Investment Research
uniQure N.V. (QURE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
   Earnings Preview: uniQure (QURE) Q1 Earnings Expected to Decline  2020/04/27 16:32:07 Zacks Investment Research
UniQure (QURE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   uniQure EPS misses by $0.29, beats on revenue  2020/03/02 21:13:02 Seeking Alpha
uniQure (NASDAQ:QURE): FY GAAP EPS of -$3.11 misses by $0.29. Revenue of $7.28M (-35.5% Y/Y) beats by $1.19M. Press Release
   UniQure (QURE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?  2020/02/20 17:31:47 Zacks Investment Research
UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Gene Therapy Names Moving On The Audentes Buyout Deal  2019/12/03 16:53:46 Benzinga
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/ADR (OTC: ALPMY ) for $60 per share, representing a 110% premium over Audentes' Monday closing price. Audentes shares are trading close to the offer price, and the news has lifted other gene therapy names. The movers include: Uniqure NV (NASDAQ: QURE ), up 15.92% to $63.50. Uniqure's CEO is also participating in a fireside chat at the Piper Jaffray Healthcare Conference Tuesday. Abeona Therapeutics Inc (NASDAQ: ABEO ), up 1.17%% to $3.45. Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ), up 4.72% to $11.53. Regenxbio Inc (NASDAQ: RGNX ), up 9.76% to $44.65. Sangamo Therapeutics Inc (NASDAQ: SGMO ), up 6.27% to $11.36. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ), up 0.28% to $80.08. Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ), … Full story available on Benzinga.com
   Moving Average Crossover Alert: uniQure  2020/06/01 13:29:00 Zacks Investment Research
uniQure N.V. (QURE) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
   Earnings Preview: uniQure (QURE) Q1 Earnings Expected to Decline  2020/04/27 16:32:07 Zacks Investment Research
UniQure (QURE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   uniQure EPS misses by $0.29, beats on revenue  2020/03/02 21:13:02 Seeking Alpha
uniQure (NASDAQ:QURE): FY GAAP EPS of -$3.11 misses by $0.29. Revenue of $7.28M (-35.5% Y/Y) beats by $1.19M. Press Release
   UniQure (QURE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?  2020/02/20 17:31:47 Zacks Investment Research
UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Gene Therapy Names Moving On The Audentes Buyout Deal  2019/12/03 16:53:46 Benzinga
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/ADR (OTC: ALPMY ) for $60 per share, representing a 110% premium over Audentes' Monday closing price. Audentes shares are trading close to the offer price, and the news has lifted other gene therapy names. The movers include: Uniqure NV (NASDAQ: QURE ), up 15.92% to $63.50. Uniqure's CEO is also participating in a fireside chat at the Piper Jaffray Healthcare Conference Tuesday. Abeona Therapeutics Inc (NASDAQ: ABEO ), up 1.17%% to $3.45. Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ), up 4.72% to $11.53. Regenxbio Inc (NASDAQ: RGNX ), up 9.76% to $44.65. Sangamo Therapeutics Inc (NASDAQ: SGMO ), up 6.27% to $11.36. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ), up 0.28% to $80.08. Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ), … Full story available on Benzinga.com
   Earnings Preview: uniQure (QURE) Q1 Earnings Expected to Decline  2020/04/27 16:32:07 Zacks Investment Research
UniQure (QURE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   uniQure EPS misses by $0.29, beats on revenue  2020/03/02 21:13:02 Seeking Alpha
uniQure (NASDAQ:QURE): FY GAAP EPS of -$3.11 misses by $0.29. Revenue of $7.28M (-35.5% Y/Y) beats by $1.19M. Press Release
   UniQure (QURE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?  2020/02/20 17:31:47 Zacks Investment Research
UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Gene Therapy Names Moving On The Audentes Buyout Deal  2019/12/03 16:53:46 Benzinga
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD ) announced a deal late Monday to be acquired by Japanese pharma company ASTELLAS PHARMA/ADR (OTC: ALPMY ) for $60 per share, representing a 110% premium over Audentes' Monday closing price. Audentes shares are trading close to the offer price, and the news has lifted other gene therapy names. The movers include: Uniqure NV (NASDAQ: QURE ), up 15.92% to $63.50. Uniqure's CEO is also participating in a fireside chat at the Piper Jaffray Healthcare Conference Tuesday. Abeona Therapeutics Inc (NASDAQ: ABEO ), up 1.17%% to $3.45. Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ), up 4.72% to $11.53. Regenxbio Inc (NASDAQ: RGNX ), up 9.76% to $44.65. Sangamo Therapeutics Inc (NASDAQ: SGMO ), up 6.27% to $11.36. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ), up 0.28% to $80.08. Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ), … Full story available on Benzinga.com
   uniQure N.V. (QURE) Shares March Higher, Can It Continue?  2019/10/30 14:38:00 Zacks Investment Research
As of late, it has definitely been a great time to be an investor in uniQure N.V. (QURE).

calendar